{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:27:16Z","timestamp":1792016836371,"version":"4.4.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2015,8,3]],"date-time":"2015-08-03T00:00:00Z","timestamp":1438560000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1038\/nm.3917","type":"journal-article","created":{"date-parts":[[2015,8,3]],"date-time":"2015-08-03T11:16:43Z","timestamp":1438600603000},"page":"1085-1090","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":243,"title":["Myostatin is a direct regulator of osteoclast differentiation and its inhibition reduces inflammatory joint destruction in mice"],"prefix":"10.1038","volume":"21","author":[{"given":"Berno","family":"Dankbar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Fennen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Brunert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Hayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinna","family":"Wehmeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Beckmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Paruzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Bertrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"Redlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Koers-Wunrau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Stratis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adelheid","family":"Korb-Pap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Pap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,8,3]]},"reference":[{"key":"BFnm3917_CR1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/387083a0","volume":"387","author":"AC McPherron","year":"1997","unstructured":"McPherron, A.C., Lawler, A.M. & Lee, S.J. Regulation of skeletal muscle mass in mice by a new TGF-\u03b2 superfamily member. Nature 387, 83\u201390 (1997).","journal-title":"Nature"},{"key":"BFnm3917_CR2","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.cellsig.2011.05.003","volume":"23","author":"Z Huang","year":"2011","unstructured":"Huang, Z., Chen, X. & Chen, D. Myostatin: a novel insight into its role in metabolism, signal pathways, and expression regulation. Cell. Signal. 23, 1441\u20131446 (2011).","journal-title":"Cell. Signal."},{"key":"BFnm3917_CR3","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1006\/bbrc.2002.6500","volume":"291","author":"J Lin","year":"2002","unstructured":"Lin, J. et al. Myostatin knockout in mice increases myogenesis and decreases adipogenesis. Biochem. Biophys. Res. Commun. 291, 701\u2013706 (2002).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnm3917_CR4","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1073\/pnas.0408729102","volume":"102","author":"KR Wagner","year":"2005","unstructured":"Wagner, K.R., Liu, X., Chang, X. & Allen, R.E. Muscle regeneration in the prolonged absence of myostatin. Proc. Natl. Acad. Sci. USA 102, 2519\u20132524 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm3917_CR5","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1242\/jcs.02482","volume":"118","author":"S McCroskery","year":"2005","unstructured":"McCroskery, S. et al. Improved muscle healing through enhanced regeneration and reduced fibrosis in myostatin-null mice. J. Cell Sci. 118, 3531\u20133541 (2005).","journal-title":"J. Cell Sci."},{"key":"BFnm3917_CR6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.bone.2008.08.126","volume":"44","author":"E Kellum","year":"2009","unstructured":"Kellum, E. et al. Myostatin (GDF-8) deficiency increases fracture callus size, Sox-5 expression, and callus bone volume. Bone 44, 17\u201323 (2009).","journal-title":"Bone"},{"key":"BFnm3917_CR7","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/j.bone.2007.02.012","volume":"40","author":"MW Hamrick","year":"2007","unstructured":"Hamrick, M.W. et al. Loss of myostatin (GDF8) function increases osteogenic differentiation of bone marrow-derived mesenchymal stem cells but the osteogenic effect is ablated with unloading. Bone 40, 1544\u20131553 (2007).","journal-title":"Bone"},{"key":"BFnm3917_CR8","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/ar.a.10044","volume":"272","author":"MW Hamrick","year":"2003","unstructured":"Hamrick, M.W. Increased bone mineral density in the femora of GDF8 knockout mice. Anat. Rec. A Discov. Mol. Cell. Evol. Biol. 272, 388\u2013391 (2003).","journal-title":"Anat. Rec. A Discov. Mol. Cell. Evol. Biol."},{"key":"BFnm3917_CR9","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0736-0266(03)00105-0","volume":"21","author":"MW Hamrick","year":"2003","unstructured":"Hamrick, M.W., Pennington, C. & Byron, C.D. Bone architecture and disc degeneration in the lumbar spine of mice lacking GDF-8 (myostatin). J. Orthop. Res. 21, 1025\u20131032 (2003).","journal-title":"J. Orthop. Res."},{"key":"BFnm3917_CR10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.archoralbio.2005.05.008","volume":"51","author":"EK Nicholson","year":"2006","unstructured":"Nicholson, E.K., Stock, S.R., Hamrick, M.W. & Ravosa, M.J. Biomineralization and adaptive plasticity of the temporomandibular joint in myostatin knockout mice. Arch. Oral Biol. 51, 37\u201349 (2006).","journal-title":"Arch. Oral Biol."},{"key":"BFnm3917_CR11","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.bone.2013.12.002","volume":"60","author":"P Bialek","year":"2014","unstructured":"Bialek, P. et al. A myostatin and activin decoy receptor enhances bone formation in mice. Bone 60, 162\u2013171 (2014).","journal-title":"Bone"},{"key":"BFnm3917_CR12","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1002\/j.1460-2075.1991.tb04978.x","volume":"10","author":"J Keffer","year":"1991","unstructured":"Keffer, J. et al. Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J. 10, 4025\u20134031 (1991).","journal-title":"EMBO J."},{"key":"BFnm3917_CR13","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00223-002-1049-y","volume":"73","author":"SR Goldring","year":"2003","unstructured":"Goldring, S.R. Inflammatory mediators as essential elements in bone remodeling. Calcif. Tissue Int. 73, 97\u2013100 (2003).","journal-title":"Calcif. Tissue Int."},{"key":"BFnm3917_CR14","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1136\/ard.2008.104786","volume":"69","author":"K Polzer","year":"2010","unstructured":"Polzer, K. et al. Interleukin-1 is essential for systemic inflammatory bone loss. Ann. Rheum. Dis. 69, 284\u2013290 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnm3917_CR15","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/rheumatology\/39.2.122","volume":"39","author":"DL Scott","year":"2000","unstructured":"Scott, D.L. et al. The links between joint damage and disability in rheumatoid arthritis. Rheumatology 39, 122\u2013132 (2000).","journal-title":"Rheumatology"},{"key":"BFnm3917_CR16","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/00002281-200207000-00013","volume":"14","author":"SR Goldring","year":"2002","unstructured":"Goldring, S.R. Pathogenesis of bone erosions in rheumatoid arthritis. Curr. Opin. Rheumatol. 14, 406\u2013410 (2002).","journal-title":"Curr. Opin. Rheumatol."},{"key":"BFnm3917_CR17","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1136\/ard.62.3.196","volume":"62","author":"H Tsuboi","year":"2003","unstructured":"Tsuboi, H. et al. Tartrate resistant acid phosphatase (TRAP) positive cells in rheumatoid synovium may induce the destruction of articular cartilage. Ann. Rheum. Dis. 62, 196\u2013203 (2003).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnm3917_CR18","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1172\/JCI0215582","volume":"110","author":"K Redlich","year":"2002","unstructured":"Redlich, K. et al. Osteoclasts are essential for TNF-\u03b1-mediated joint destruction. J. Clin. Invest. 110, 1419\u20131427 (2002).","journal-title":"J. Clin. Invest."},{"key":"BFnm3917_CR19","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/ar2110","volume":"9","author":"G Schett","year":"2007","unstructured":"Schett, G. Cells of the synovium in rheumatoid arthritis. Osteoclasts. Arthritis Res. Ther. 9, 203 (2007).","journal-title":"Arthritis Res. Ther."},{"key":"BFnm3917_CR20","first-page":"1154","volume":"25","author":"Y Suzuki","year":"1998","unstructured":"Suzuki, Y., Nishikaku, F., Nakatuka, M. & Koga, Y. Osteoclast-like cells in murine collagen induced arthritis. J. Rheumatol. 25, 1154\u20131160 (1998).","journal-title":"J. Rheumatol."},{"key":"BFnm3917_CR21","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.0105-2896.2005.00338.x","volume":"208","author":"NC Walsh","year":"2005","unstructured":"Walsh, N.C., Crotti, T.N., Goldring, S.R. & Gravallese, E.M. Rheumatic diseases: the effects of inflammation on bone. Immunol. Rev. 208, 228\u2013251 (2005).","journal-title":"Immunol. Rev."},{"key":"BFnm3917_CR22","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1359\/JBMR.0301233","volume":"19","author":"P Li","year":"2004","unstructured":"Li, P. et al. RANK signalling is not required for TNF-\u03b1-mediated increase in CD11hi osteoclast precursors but is essential for mature osteoclast formation in TNF-\u03b1-mediated inflammatory arthritis. J. Bone Miner. Res. 19, 207\u2013213 (2004).","journal-title":"J. Bone Miner. Res."},{"key":"BFnm3917_CR23","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1172\/JCI11176","volume":"106","author":"J Lam","year":"2000","unstructured":"Lam, J. et al. TNF-\u03b1 induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J. Clin. Invest. 106, 1481\u20131488 (2000).","journal-title":"J. Clin. Invest."},{"key":"BFnm3917_CR24","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1172\/JCI200316069","volume":"111","author":"CT Ritchlin","year":"2003","unstructured":"Ritchlin, C.T., Haas-Smith, S.A., Li, P., Hicks, D.G. & Schwarz, E.M. Mechanisms of TNF-\u03b1- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis. J. Clin. Invest. 111, 821\u2013831 (2003).","journal-title":"J. Clin. Invest."},{"key":"BFnm3917_CR25","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/319516a0","volume":"319","author":"DR Bertolini","year":"1986","unstructured":"Bertolini, D.R., Nedwin, G.E., Bringman, T.S., Smith, D.D. & Mundy, G.R. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. Nature 319, 516\u2013518 (1986).","journal-title":"Nature"},{"key":"BFnm3917_CR26","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1007\/s00018-008-8077-3","volume":"65","author":"L Bradley","year":"2008","unstructured":"Bradley, L., Yaworsky, P.J. & Walsh, F.S. Myostatin as a therapeutic target for musculoskeletal disease. Cell. Mol. Life Sci. 65, 2119\u20132124 (2008).","journal-title":"Cell. Mol. Life Sci."},{"key":"BFnm3917_CR27","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1006\/bbrc.2000.2075","volume":"268","author":"K Fuller","year":"2000","unstructured":"Fuller, K., Bayley, K.E. & Chambers, T.J. Activin A is an essential cofactor for osteoclast induction. Biochem. Biophys. Res. Commun. 268, 2\u20137 (2000).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnm3917_CR28","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/jcb.10613","volume":"90","author":"T Sugatani","year":"2003","unstructured":"Sugatani, T., Alvarez, U.M. & Hruska, K.A. Activin A stimulates I\u03baB-\u03b1\/NF\u03baB and RANK expression for osteoclast differentiation, but not AKT survival pathway in osteoclast precursors. J. Cell. Biochem. 90, 59\u201367 (2003).","journal-title":"J. Cell. Biochem."},{"key":"BFnm3917_CR29","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1177\/00220345990780100601","volume":"78","author":"N Tani-Ishii","year":"1999","unstructured":"Tani-Ishii, N., Tsunoda, A., Teranaka, T. & Umemoto, T. Autocrine regulation of osteoclast formation and bone resorption by IL-1 alpha and TNF alpha. J. Dent. Res. 78, 1617\u20131623 (1999).","journal-title":"J. Dent. Res."},{"key":"BFnm3917_CR30","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1136\/annrheumdis-2011-200386","volume":"71","author":"A Korb-Pap","year":"2012","unstructured":"Korb-Pap, A. et al. Early structural changes in cartilage and bone are required for the attachment and invasion of inflamed synovial tissue during destructive inflammatory arthritis. Ann. Rheum. Dis. 71, 1004\u20131011 (2012).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnm3917_CR31","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0006-291X(03)00695-8","volume":"305","author":"ZH Lee","year":"2003","unstructured":"Lee, Z.H. & Kim, H.H. Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts. Biochem. Biophys. Res. Commun. 305, 211\u2013214 (2003).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnm3917_CR32","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S8756-3282(01)00657-3","volume":"30","author":"SE Lee","year":"2002","unstructured":"Lee, S.E. et al. The phosphatidylinositol 3-kinase, p38, and extracellular signal-regulated kinase pathways are involved in osteoclast differentiation. Bone 30, 71\u201377 (2002).","journal-title":"Bone"},{"key":"BFnm3917_CR33","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1210\/endo.143.8.8954","volume":"143","author":"X Li","year":"2002","unstructured":"Li, X. et al. p38 MAPK-mediated signals are required for inducing osteoclast differentiation but not for osteoclast function. Endocrinology 143, 3105\u20133113 (2002).","journal-title":"Endocrinology"},{"key":"BFnm3917_CR34","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/jbmr.2418","volume":"30","author":"Y Omata","year":"2015","unstructured":"Omata, Y. et al. Genome-wide comprehensive analysis reveals critical cooperation between Smad and c-Fos in RANKL-induced osteoclastogenesis. J. Bone Miner. Res. 30, 869\u2013877 (2015).","journal-title":"J. Bone Miner. Res."},{"key":"BFnm3917_CR35","doi-asserted-by":"crossref","first-page":"19371","DOI":"10.1074\/jbc.M802585200","volume":"283","author":"ZB Li","year":"2008","unstructured":"Li, Z.B., Kollias, H.D. & Wagner, K.R. Myostatin directly regulates skeletal muscle fibrosis. J. Biol. Chem. 283, 19371\u201319378 (2008).","journal-title":"J. Biol. Chem."},{"key":"BFnm3917_CR36","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1530\/eje.0.1430705","volume":"143","author":"H Machida","year":"2000","unstructured":"Machida, H., Ogawa, K., Funaba, M., Mizutani, T. & Tsujimoto, M. mRNA expression of type I and type II receptors for activin, transforming growth factor-beta, and bone morphogenetic protein in the murine erythroleukemic cell line, F5-5.fl. Eur. J. Endocrinol. 143, 705\u2013710 (2000).","journal-title":"Eur. J. Endocrinol."},{"key":"BFnm3917_CR37","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1046\/j.1523-1755.1999.00790.x","volume":"56","author":"H Kaneto","year":"1999","unstructured":"Kaneto, H. et al. Increased expression of TGF-\u03b21 but not its receptor contributes to human obstructive nephropathy. Kidney Int. 56, 2137\u20132146 (1999).","journal-title":"Kidney Int."},{"key":"BFnm3917_CR38","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1124\/mol.62.1.65","volume":"62","author":"GJ Inman","year":"2002","unstructured":"Inman, G.J. et al. SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol. Pharmacol. 62, 65\u201374 (2002).","journal-title":"Mol. Pharmacol."},{"key":"BFnm3917_CR39","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.nbd.2006.05.009","volume":"23","author":"EL Holzbaur","year":"2006","unstructured":"Holzbaur, E.L. et al. Myostatin inhibition slows muscle atrophy in rodent models of amyotrophic lateral sclerosis. Neurobiol. Dis. 23, 697\u2013707 (2006).","journal-title":"Neurobiol. Dis."},{"key":"BFnm3917_CR40","doi-asserted-by":"crossref","first-page":"15.22.1","DOI":"10.1002\/0471142735.im1522s81","volume":"81","author":"PA Monach","year":"2008","unstructured":"Monach, P.A., Mathis, D. & Benoist, C. The K\/BxN arthritis model. Curr. Protoc. Immunol. 81, 15.22.1\u201315.22.12 (2008).","journal-title":"Curr. Protoc. Immunol."},{"key":"BFnm3917_CR41","doi-asserted-by":"crossref","first-page":"29039","DOI":"10.1074\/jbc.C110.155820","volume":"285","author":"GJ Martinez","year":"2010","unstructured":"Martinez, G.J. et al. Smad2 positively regulates the generation of Th17 cells. J. Biol. Chem. 285, 29039\u201329043 (2010).","journal-title":"J. Biol. Chem."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm.3917.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.3917","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.3917.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T18:51:26Z","timestamp":1684435886000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm.3917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,3]]},"references-count":41,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["BFnm3917"],"URL":"https:\/\/doi.org\/10.1038\/nm.3917","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725693209.793510026","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.725693209.793510269","asserted-by":"object"}]},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,3]]},"assertion":[{"value":"6 May 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}